期刊
SCIENCE
卷 327, 期 5962, 页码 217-220出版社
AMER ASSOC ADVANCEMENT SCIENCE
DOI: 10.1126/science.1176827
关键词
-
资金
- Swedish Research Council
- European Foundation for the Study of Diabetes
- Novo Nordisk and Albert Pahlsson foundations
- Kungliga Fysiografiska Sallskapet
- Nordic Centre of Excellence in Disease Genetics (NCoEDG)
- Lund University Diabetes Centre
- Knut and Alice Wallenberg Foundation
- Novo Nordisk Fonden [NNF10OC1013350] Funding Source: researchfish
Several common genetic variations have been associated with type 2 diabetes, but the exact disease mechanisms are still poorly elucidated. Using congenic strains from the diabetic Goto-Kakizaki rat, we identified a 1.4-megabase genomic locus that was linked to impaired insulin granule docking at the plasma membrane and reduced beta cell exocytosis. In this locus, Adra2a, encoding the alpha2A-adrenergic receptor [alpha(2A)AR], was significantly overexpressed. Alpha(2A) AR mediates adrenergic suppression of insulin secretion. Pharmacological receptor antagonism, silencing of receptor expression, or blockade of downstream effectors rescued insulin secretion in congenic islets. Furthermore, we identified a single-nucleotide polymorphism in the human ADRA2A gene for which risk allele carriers exhibited overexpression of alpha(2A) AR, reduced insulin secretion, and increased type 2 diabetes risk. Human pancreatic islets from risk allele carriers exhibited reduced granule docking and secreted less insulin in response to glucose; both effects were counteracted by pharmacological alpha(2A) AR antagonists.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据